Data-Driven Monitoring for Speaker Programs
Live webinar
Thursday, Nov 18, 2021 at 1:00 PM EDT
Key Take-aways:
- The Speaker Program risks emphasized by the OIG
- Speaker Program-specific Compliance requirements updates
- Why tracking data is important for Sales, Marketing, and Compliance
- How to use data for targeting risk-based Programs for live monitoring
- Automated audits of Speaker Program data
Overview:
In the November of 2020, the OIG issued a Special Fraud Alert for speaker programs in the life sciences industry. Following this alert, the PhRMA Code was also revised in August 2021 to help the industry prepare well and adhere to the regulations around speaker programs.
Continuing our streak of bringing the most updated and valuable content for our compliance community, we’re tying up with Sharon R. Delshad, Principal at Rebel Compliance to share recommended uses of data for planning and conducting monitoring and auditing of Speaker Programs based on the 2020 OIG Special Fraud Alert on Speaker Programs, recent Corporate Integrity Agreements, and updates to the 2021 PhRMA Code on Interactions with Healthcare Provider.
Speakers:
Sharon R. Delshad
Principal, Rebel Compliance
Sharon R. Delshad is a compliance consultant and attorney with over 10 years’ experience supporting life sciences companies as an in-house Compliance Director and Big 4 consultant with EY and PwC. She is a compliance generalist who has worked in depth on all aspects of Healthcare Compliance for companies of all sizes – from large companies under Corporate Integrity Agreements through emerging companies designing their Programs.
Mohammad Ovais
Founder & CEO, qordata
Mohammad Ovais is the Founder & CEO at qordata and has spent a decade building analytical solutions and applications for Fortune 1000 companies. Prior to this, he served as the Managing Partner/Co-Founder at Streebo. With a Bachelor in Computer Science from Rice University and EMP from MIT, he serves on the board of Entrepreneur Organization as Strategic Alliances Chair.
Who should attend?
Mid-level to Senior Compliance professionals at drug or medical device manufacturing companies, legal consultants working in the life sciences compliance industry.
Live and recorded sessions
Dedicated Q&A section during the webinar to provide every possible value to you
Featuring experienced and subject matter experts to bring you the most relevant and up to date knoweldge
On-demand webinar access, to provide you with the recorded sessions of our past webinars